June saw the coming together of leading physicians, scientists, and healthcare professionals at two key metabolic conferences: ADA 2023 and EASL 2023. These meetings serve as nerve centres for groundbreaking research, insightful dialogue, and alliances that could drive the next advances in diabetes and hepatology.
This eBook is an essential read for anyone who wants a rundown of the scientific findings unveiled at these two meetings. The Evaluate Vantage team cuts through the noise to bring you the critical news and data, along with incisive analysis of major developments, potential industry disruptors, and the market implications
